The use of recombinant factor VIIa in a patient with essential thrombocythaemia with uncontrolled surgical bleeding.
Cervera
José Sanchis
JS
Department of Haematology, Hospital de La Plana, Villareal, Castellón, Spain. bloodies@mail.ono.es
Mena-Durán
Armando V
AV
Piqueras
Cristina Sanchis
CS
D000368:Aged; D001773:Blood Cells; D016063:Blood Loss, Surgical; D001856:Bone Marrow Examination; D005167:Factor VII / Q000627:therapeutic use*; D015942:Factor VIIa; D005260:Female; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology / Q000628:therapy; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use*; D013920:Thrombocythemia, Essential / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy
D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa